Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Seres Therapeutics
Biotech
Bavarian Nordic CEO exits after failed takeover—Chutes & Ladders
Bavarian Nordic CEO exits on heels of failed takeover. Absci appoints Vertex vet as chief medical officer. FDA’s operations chief to hang up hat.
Darren Incorvaia
,
Zoey Becker
,
Will Maddox
Mar 6, 2026 8:30am
Seres to lay off 30% of employees, pause lead program
Feb 12, 2026 9:55am
Seres shrinks head count by 25% to fund biotherapeutic's ph. 2
Sep 23, 2025 10:00am
Ikena and Inmagene choose combined CEO—Chutes & Ladders
Jul 25, 2025 8:30am
Seres slims R&D, staff to focus on approved microbiome drug
Nov 2, 2023 12:22pm
Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders
Aug 25, 2023 9:30am